FertyBiotic Woman

FertyBiotic Woman

Myo-Inositol + DCI 40:1 · Melatonin · Oocyte Quality & Implantation (Non-PCOS)

256.50 SAR

Category:

Clinical Problem

Poor oocyte quality, low ovarian reserve, and implantation failure are the leading causes of ART failure in non-PCOS women. Mitochondrial dysfunction in oocytes, oxidative damage in follicular fluid, and endometrial microbiome imbalance collectively impair fertilisation and implantation.

Target Patient

Low ovarian reserve (diminished AMH)

Poor oocyte quality pre-IVF

Implantation failure — recurrent

Women TTC without PCOS diagnosis

Pre-IVF / ART preparation

History of early miscarriage

Product Benefits

Oocyte Quality & Maturation

Myo-Inositol 1,809.5mg + DCI 190.5mg at physiological 40:1 ratio — mirrors ovarian tissue physiology. Restores follicle function and oocyte maturation signalling.

Melatonin Antioxidant Protection

Melatonin 1mg in follicular fluid. Bedtime dosing maximises antioxidant action when follicles are most vulnerable to oxidative damage.

Endometrial Receptivity

Vit D3 600IU (150% RDA) + Inositols synergistically improve endometrial receptivity — critical for implantation success.

Gut-Vaginal Axis Support

3-strain Lactobacillus blend 3B CFU. Reduces implantation failure risk through vaginal microbiome optimisation.

Treatment Areas

Male infertility · Oligospermia · Asthenospermia · DNA fragmentation · IVF/ICSI preparation · Oxidative seminal stress

Pre-IVF preparation

Poor oocyte quality

Low ovarian reserve

Implantation failure

Women TTC (non-PCOS)

Product Composition

Myo-Inositol1,809.5mg · restores follicle function · FSH receptor sensitivity
D-Chiro-Inositol (DCI)190.5mg · physiological 40:1 MI:DCI ratio · mirrors ovarian tissue
Melatonin1mg · antioxidant in follicular fluid · bedtime dosing
Vitamin D3600 IU (150% RDA) · endometrial receptivity · Gulf-region appropriate dose
Selenium55µg · oocyte DNA protection · antioxidant enzyme co-factor
Folic Acid400µg · DNA methylation · neural tube protection
Lactobacillus blend3-strain · 3 Billion CFU · gut-vaginal axis support

Clinical Results

40:1

MI:DCI Physiological Ratio

↑ Oocyte

Quality & Maturation

↑ Implant.

Success Rate

3B CFU

Lactobacillus Blend

150%

RDA Vitamin D3

Bedtime

Optimal Dosing

Clinical Results

Dosage

1 Sachet / Day

2 sachets if BMI >25

Duration

30 Days / Cycle

Continue per HCP / ART protocol

Timing

Bedtime

Maximises melatonin efficacy

IVF Preparation

3 Months Before

For folliculogenesis alignment

Treatment Areas

Pre-IVF preparation · Poor oocyte quality · Low ovarian reserve · Implantation failure · Women TTC (non-PCOS)

Frequently Asked Questions

Why is the 40:1 Myo-Inositol:DCI ratio important?
The 40:1 ratio mirrors the physiological MI:DCI concentration found in healthy ovarian follicular fluid. Supplementing at this ratio restores the second messenger signalling system for FSH, improving follicular response and oocyte maturation.
 
Why is Vitamin D3 at 150% RDA?
Vitamin D3 deficiency is endemic in the Gulf region due to sun avoidance and indoor lifestyle. The 600IU dose corrects deficiency while providing the endometrial receptivity and ovarian function benefits documented at adequate D3 levels.
 
Can FertyBiotic Woman be taken as part of the Couples Protocol?

Yes — FertyBiotic Woman is designed for simultaneous use with Androbiane (male partner), commencing 3 months before the IVF cycle for optimal folliculogenesis and spermatogenesis alignment.

Scientific References

  1. Unfer et al. · Myo-Inositol and D-Chiro-Inositol at 40:1 ratio in women with poor ovarian response · Gynecol Endocrinol
     
  2. Tamura et al. · Melatonin in follicular fluid and oocyte quality · Journal of Pineal Research
     
  3. Vitamin D and endometrial receptivity — systematic review · Human Reproduction
Duration

All clinical data referenced from published peer-reviewed sources. For professional use by qualified healthcare providers only. Not for patient self-diagnosis or treatment.

RELATED PRODUCTS